Vortioxetine 5 mg / 10 mg / 15 mg / 20 mg
Image
Product Description
- A novel Atypical antidepressant with a multimodal mechanism of action that combines modulation of 5-HT receptor activity with inhibition of the SERT.
- An effective initial and maintenance treatment for major depressive disorder patients (MDD).
- The first and only antidepressant that improves cognitive function associated with daily functioning at work, home and socially.
- Improves all the multiple symptoms of MDD including physical, cognitive and mood symptoms.
- Achieved the best balance between efficacy and tolerability.
- Achieves superior response and remission rates in patients who had a partial response to an SSRI or SNRI.
- Does not exhibit many side effects as typical SSRIs and SNRIs such as sexual dysfunction, weight gain, and sleep disturbances.
- Does not affect driving performance.
- Can be stopped abruptly, without the need for gradual dose reduction due to its long half-life (66 hours).
- Is given once daily without regard to food and at any time of the day.